Gene–Gene Interactions Between Glutathione S-Transferase M1 and Matrix Metalloproteinases 1, 9, and 12 in Chronic Obstructive Pulmonary Disease in Serbians

References

• Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221.
   PubMedGoogle Scholar
• Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415.
   PubMed Web of Science ®Google Scholar
• Macnee W. Pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med. 2007;28(3):479–513.
   PubMed Web of Science ®Google Scholar
• Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(2):253–268.
   PubMedGoogle Scholar
• Bolt HM, Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 2006;7(6):613–628.
   PubMed Web of Science ®Google Scholar
• Fischer BM, Voynow JA, Ghio AJ. COPD: balancing oxidants and antioxidants. Int J Chron Obstruct Pulmon Dis. 2015;10:261–276.
   PubMed Web of Science ®Google Scholar
• Wu W, Peden D, Diaz-Sanchez D. Role of GSTM1 in resistance to lung inflammation. Free Radic Biol Med. 2012;53(4):721–729.
   PubMed Web of Science ®Google Scholar
• Bossé Y. Updates on the COPD gene list. Int J Chron Obstruct Pulmon Dis. 2012;7:607–631.
   PubMed Web of Science ®Google Scholar
• Navratilova Z, Kolek V, Petrek M. Matrix metalloproteinases and their inhibitors in chronic obstructive pulmonary disease. Arch Immunol Ther Exp (Warsz). 2016;64(3):177–193.
   PubMed Web of Science ®Google Scholar
• Segura-Valdez L, Pardo A, Gaxiola M, Uhal BD, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 2000;117(3):684–694.
   PubMed Web of Science ®Google Scholar
• Gosselink JV, Hayashi S, Elliott WM, et al. Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(12):1329–1335.
   PubMed Web of Science ®Google Scholar
• Molet S, Belleguic C, Lena H, et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res. 2005;54(1):31–36.
   PubMed Web of Science ®Google Scholar
• Chaudhuri R, McSharry C, Brady J, et al. Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity. J Allergy Clin Immunol. 2012;129(3):655–663.
   PubMed Web of Science ®Google Scholar
• Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99(14):1788–1794.
   PubMed Web of Science ®Google Scholar
• Rutter JL, Mitchell TI, Butticè G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58(23):5321–5325.
   PubMed Web of Science ®Google Scholar
• Jormsjö S, Ye S, Moritz J, et al. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res. 2000;86(9):998–1003.
   PubMed Web of Science ®Google Scholar
• Trojanek JB, Cobos-Correa A, Diemer S, et al. Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema. Am J Respir Cell Mol Biol. 2014;51(5):709–720.
   PubMed Web of Science ®Google Scholar
• Elkington PT, Cooke GS. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2010;362(13):1241.
   PubMed Web of Science ®Google Scholar
• Korytina GF, Akhmadishina LZ, Viktorova EV, et al. Extracellular matrix remodeling genes polymorphisms and risk of chronic bronchitis and recurrent pneumonia in children. J Hum Genet. 2013;58(7):467–474.
   PubMed Web of Science ®Google Scholar
• Korytina GF, Akhmadishina LZ, Ianbaeva DG, Viktorova TV. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients]. Genetika. 2008;44(2):242–249.
   PubMedGoogle Scholar
• Haq I, Chappell S, Johnson SR, et al. Association of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population. BMC Med Genet. 2010;11:7.
   PubMed Web of Science ®Google Scholar
• Schirmer H, Basso da Silva L, Teixeira PJ, Moreira JS, Moreira AL, Simon D. Matrix metalloproteinase gene polymorphisms: lack of association with chronic obstructive pulmonary disease in a Brazilian population. Genet Mol Res. 2009;8(3):1028–1034.
   PubMed Web of Science ®Google Scholar
• Bchir S, Nasr HB, Anes AB, et al. MMP-2 (−1306 C/T) polymorphism affects serum matrix metalloproteinase (MMP)-2 levels and correlates with chronic obstructive pulmonary disease severity: a case-control study of MMP-1 and −2 in a Tunisian population. Mol Diagn Ther. 2016;20(6):579–590.
   PubMed Web of Science ®Google Scholar
• Tesfaigzi Y, Myers OB, Stidley CA, et al. Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(3):267–278.
   PubMedGoogle Scholar
• Stankovic M, Nikolic A, Tomovic A, et al. Association of functional variants of phase I and II genes with chronic obstructive pulmonary disease in Serbian population. J Med Biochem. 2015;34(2):207–214.
   PubMed Web of Science ®Google Scholar
• Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002;11(5):569–576.
   PubMed Web of Science ®Google Scholar
• Zidzik J, Slabá E, Joppa P, et al. Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J. 2008;49(2):182–191.
   PubMed Web of Science ®Google Scholar
• Cheng SL, Yu CJ, Chen CJ, Yang PC. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J. 2004;23(6):818–824.
   PubMed Web of Science ®Google Scholar
• He JQ, Ruan J, Connett JE, Anthonisen NR, Paré PD, Sandford AJ. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med. 2002;166(3):323–328.
   PubMed Web of Science ®Google Scholar
• Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev. 2007;87(1):69–98.
   PubMed Web of Science ®Google Scholar
• Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta. 2007;1773(8):1358–1375.
   PubMed Web of Science ®Google Scholar
• Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol. 2003;170(12):6244–6249.
   PubMed Web of Science ®Google Scholar
• Stankovic M, Nikolic A, Divac A, et al. Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis. J Investig Med. 2009;57(3):500–503.
   PubMed Web of Science ®Google Scholar
• Stankovic M, Kojic S, Djordjevic V, et al. Gene-environment interaction between the MMP9 C-1562T promoter variant and cigarette smoke in the pathogenesis of chronic obstructive pulmonary disease. Environ Mol Mutagen. 2016;57(6):447–454.
   PubMed Web of Science ®Google Scholar
• Gross NJ. The GOLD standard for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(5):1047–1048.
   PubMed Web of Science ®Google Scholar
• Ottman R. Gene-environment interaction: definitions and study designs. Prev Med. 1996;25(6):764–770.
   PubMed Web of Science ®Google Scholar
• Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002;11(20):2463–2468.
   PubMed Web of Science ®Google Scholar
• Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236–1238.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang T, Liu L, Shen Y, Wan C, Wen F. Matrix metalloproteinase-9 -1562C/T promoter polymorphism confers risk for COPD: a meta-analysis. PLoS One. 2013;8(3):e60523.
   PubMed Web of Science ®Google Scholar
• Zhou H, Wu Y, Jin Y, et al. Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis. Sci Rep. 2013;3:2818.
   PubMed Web of Science ®Google Scholar
• Jiang S, Yang ZH, Chen YY, et al. MMP-9 genetic polymorphism may confer susceptibility to COPD. Genet Mol Res. 2016;15(2).
   Web of Science ®Google Scholar
• Xue H, Su J, Sun K, Xie W, Wang H. Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis. Mol Biol Rep. 2012;39(4):5033–5042.
   PubMed Web of Science ®Google Scholar
• Li J, Ghio AJ, Cho SH, Brinckerhoff CE, Simon SA, Liedtke W. Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS. Environ Health Perspect. 2009;117(3):400–409.
   PubMed Web of Science ®Google Scholar
• Mercer BA, Wallace AM, Brinckerhoff CE, D'Armiento JM. Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am J Respir Cell Mol Biol. 2009;40(1):4–12.
   PubMed Web of Science ®Google Scholar
• Yanchina ED, Ivchik TV, Shvarts EI, Kokosov AN, Khodzhayantz NE. Gene-gene interactions between glutathione-s transferase M1 and matrix metalloproteinase 9 in the formation of hereditary predisposition to chronic obstructive pulmonary disease. Bull Exp Biol Med. 2004;137(1):64–66.
   PubMed Web of Science ®Google Scholar
• Silverman EK, Palmer LJ. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol. 2000;22(6):645–648.
   PubMed Web of Science ®Google Scholar
• Cheng SL, Yu CJ, Yang PC. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease. Biochem Genet. 2009;47(7–8):591–601.
   PubMed Web of Science ®Google Scholar
• Ferrarotti I, Luisetti M. COPD: no gene left unturned. Lancet Respir Med. 2014;2(3):171–172.
   PubMed Web of Science ®Google Scholar